Sitryx

Description: Sitryx develops first-in-class immunometabolism therapies for immuno-oncology & inflammation, founded by leading scientists.

Country: UK

Based in: Oxford

Founded: 2018

Funding Stage: Series A/B

Tags: ['pharma', 'cell metabolism', 'therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.